105
Participants
Start Date
July 3, 2018
Primary Completion Date
May 14, 2021
Study Completion Date
May 14, 2021
EC-18
Oral administration of EC-18 twice daily
Placebo
Placebo to match EC-18 capsule administration
Mount Sinai - Union Square, New York
St. Luke's Cancer Center - Anderson Campus, Easton
Greater Baltimore Medical Center, Baltimore
Winship Cancer Institute of Emory University, Atlanta
Mount Sinai Comprehensive Cancer Center, Miami Beach
Miami Cancer Institute, Miami
University of Kentucky, Chandler Medical Center, CCTS, Lexington
NorthShore University HealthSystem, Evanston
Southern Illinois University School of Medicine, Springfield
Cancer Center of Kansas, Wichita
University of Oklahoma Health Sciences Center, Oklahoma City
Hope Cancer Center of East Texas, Tyler
Baylor Scott & White Medical Center - Hillcrest, Waco
UCLA Jonsson Comprehensive Cancer Center, Los Angeles
Veterans Affairs Long Beach Health Care System, Long Beach
Oregon Health and Science University, Portland
VA Portland HealthCare System, Portland
MultiCare Institute for Research and Innovation, Spokane
MultiCare Institute for Research and Innovation, Tacoma
Washington University School of Medicine, St Louis
Lead Sponsor
Enzychem Lifesciences Corporation
INDUSTRY